Micro Logic, a sovereign cloud provider in Canada, has been selected by Kinaxis Inc., an Ottawa, Ont.,- based provider of end-to-end supply chain orchestration, to help accelerate the company’s product innovation pipeline.
Using Micro Logic’s Cirrus AI Developer Cloud, Kinaxis will gain secure access to the NVIDIA DGX compute platform, the world’s most advanced, full-stack solution which includes NVIDIA AI Enterprise, an end-to-end, cloud-native software platform for development and deployment of production AI. The DGX platform will help company developers utilize, explore and create solutions to address the world’s most pressing supply chain challenges.
“The advent of accelerated computing, leveraging parallel processing on GPUs, revolutionized how companies can dramatically speed up calculation and started a new era for AI and HPC in general,” says Patrice Bedard, vice-president of artificial intelligence at Micro Logic. “We’re excited to help Kinaxis benefit from the power of the state-of-the-art NVIDIA platform, hardware and software, powered by Cirrus’s secure cloud environment and in the most environmentally responsible way through our sustainable data center infrastructure.”
“Kinaxis is laser-focused on empowering people through technology to harness the full potential of global supply chains, and we’re thrilled to tap the expertise of a fellow Canadian technology leader to help us deliver on this mission,” adds Gelu Ticala, executive vice-president, Engineering at Kinaxis. “No company maintains a technological leadership edge by relying on past breakthroughs and accessing the most powerful development toolset on the market is table stakes for those looking to take their product innovation efforts to the next level.”
Kinaxis was also selected by Servier, a global independent pharmaceutical group, to help revolutionize its supply chain planning capabilities with a view to accelerating time to market for its portfolio of drugs.
As part of the deployment, Kinaxis will enable Servier to plan more effectively and gain critical end-to-end visibility of its overall supply chain; a vital requirement as competing jurisdictional regulations, demand variability and increased global disruptions play havoc with the pharmaceutical industry’s mission to deliver products to customers at the lowest cost and with the shortest lead time.
Leave a Reply